Skip to main content

Table 4 Pre and post NQOL score

From: Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia

Variables Median (mean±SD) P value
Pre Post
Q1 1 (1.1 ± 1.2) 1 (1.5 ± 1.2) 0.280
Q2 2 (1.6 ± 1.3) 1 (1.1 ± 1.0) 0.048*
Q3 2 (1.3 ± 1.1) 1 (1.1 ± 1.2) 0.531
Q4 1 (1.1 ± 1.3) 1 (1.0 ± 0.8) 0.709
Q5 1 (1.6 ± 1.6) 0 (0.9 ± 1.2) 0.077
Q6 2 (2.2 ± 1.5) 2 (1.7 ± 1.3) 0.048*
Q7 2 (2.2 ± 1.4) 1 (1.6 ± 1.0) 0.070
Q8 1 (0.7 ± 0.9) 1 (1.1 ± 1.2) 0.136
Q9 1 (1.5 ± 1.5) 1 (1.4 ± 1.3) 0.806
Q10 3 (2.2 ± 1.5) 3 (2.3 ± 1.3) 0.653
Q11 3 (2.3 ± 1.5) 3 (2.4 ± 1.2) 0.634
Q12 3 (2.3 ± 1.4) 2 (2.1 ± 1.1) 0.510
Q13 4 (4.5 ± 3.1) 3 (4.1 ± 2.7) 0.604
total score 23 (24.7 ± 14.6) 23 (22.4 ± 12.3) 0.434
  1. *; p < 0.05.